(+)-catechin increases expression ISO RGD:736099 6480464 Catechin results in increased expression of ANXA2 mRNA CTD PMID:15465739 (+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of ANXA2 mRNA] CTD PMID:31150632 (-)-demecolcine increases expression ISO RGD:736099 6480464 Demecolcine results in increased expression of ANXA2 mRNA CTD PMID:23649840 1,1-dichloroethene increases expression ISO RGD:731825 6480464 vinylidene chloride results in increased expression of ANXA2 mRNA CTD PMID:26682919 1,3-dinitrobenzene increases expression EXP 6480464 3-dinitrobenzene results in increased expression of ANXA2 mRNA CTD PMID:21983209 1-chloro-2,4-dinitrobenzene increases expression ISO RGD:736099 6480464 Dinitrochlorobenzene results in increased expression of ANXA2 mRNA CTD PMID:16314067 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of ANXA2 mRNA CTD PMID:25380136 , PMID:30723492 17alpha-ethynylestradiol affects expression ISO RGD:731825 6480464 Ethinyl Estradiol affects the expression of ANXA2 mRNA CTD PMID:17555576 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of ANXA2 mRNA CTD PMID:17557909 17alpha-ethynylestradiol multiple interactions ISO RGD:731825 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ANXA2 mRNA CTD PMID:17942748 17alpha-ethynylestradiol increases expression ISO RGD:731825 6480464 Ethinyl Estradiol results in increased expression of ANXA2 mRNA CTD PMID:17942748 17beta-estradiol multiple interactions ISO RGD:736099 6480464 [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of ANXA2 mRNA CTD PMID:20823114 2,2',4,4'-Tetrabromodiphenyl ether affects expression ISO RGD:731825 6480464 2 more ... CTD PMID:30294300 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:731825 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ANXA2 mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of ANXA2 mRNA CTD PMID:20959002 , PMID:21215274 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:731825 6480464 Tetrachlorodibenzodioxin affects the expression of ANXA2 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:731825 6480464 Tetrachlorodibenzodioxin results in increased expression of ANXA2 mRNA CTD PMID:19770486 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of ANXA2 protein CTD PMID:19201780 2,3-dimethoxynaphthalene-1,4-dione increases expression ISO RGD:736099 6480464 2 more ... CTD PMID:17547211 2-[cyclohexyl(oxo)methyl]-3,6,7,11b-tetrahydro-1H-pyrazino[2,1-a]isoquinolin-4-one increases expression EXP 6480464 Praziquantel results in increased expression of ANXA2 mRNA CTD PMID:21813463 2-hydroxypropanoic acid increases expression ISO RGD:736099 6480464 Lactic Acid results in increased expression of ANXA2 mRNA CTD PMID:30851411 2-nitrofluorene increases expression EXP 6480464 2-nitrofluorene results in increased expression of ANXA2 mRNA CTD PMID:14600272 3,3',4,4',5-pentachlorobiphenyl increases expression EXP 6480464 3 more ... CTD PMID:20959002 , PMID:23196670 3-chloropropane-1,2-diol decreases expression EXP 6480464 alpha-Chlorohydrin results in decreased expression of ANXA2 mRNA CTD PMID:28522335 3-chloropropane-1,2-diol increases expression EXP 6480464 alpha-Chlorohydrin results in increased expression of ANXA2 protein CTD PMID:26072098 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4, 4'-diaminodiphenylmethane results in increased expression of ANXA2 mRNA CTD PMID:25380136 4,4'-diaminodiphenylmethane increases expression ISO RGD:731825 6480464 4, 4'-diaminodiphenylmethane results in increased expression of ANXA2 mRNA CTD PMID:18648102 4,4'-sulfonyldiphenol increases expression ISO RGD:731825 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of ANXA2 mRNA CTD PMID:30951980 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one increases expression EXP 6480464 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of ANXA2 mRNA CTD PMID:14600272 4-hydroxyphenyl retinamide decreases expression ISO RGD:731825 6480464 Fenretinide results in decreased expression of ANXA2 mRNA CTD PMID:28973697 5-aza-2'-deoxycytidine multiple interactions ISO RGD:736099 6480464 [Decitabine co-treated with Vorinostat] affects the expression of ANXA2 mRNA, [trichostatin A co-treated with Decitabine] results in increased expression of ANXA2 protein CTD PMID:17330099 , PMID:19294695 5-fluorouracil decreases response to substance ISO RGD:736099 6480464 ANXA2 mRNA results in decreased susceptibility to Fluorouracil CTD PMID:15152939 5-fluorouracil multiple interactions ISO RGD:736099 6480464 TP53 protein affects the reaction [Fluorouracil results in increased expression of ANXA2 mRNA] CTD PMID:15152939 5-fluorouracil increases expression ISO RGD:736099 6480464 Fluorouracil results in increased expression of ANXA2 mRNA CTD PMID:15152939 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of ANXA2 mRNA CTD PMID:24780913 7,12-dimethyltetraphene multiple interactions EXP 6480464 [9 more ... CTD PMID:22248470 9-cis-retinoic acid decreases expression ISO RGD:736099 6480464 Alitretinoin results in decreased expression of ANXA2 protein CTD PMID:28886987 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of ANXA2 mRNA CTD PMID:21813463 , PMID:25378103 all-trans-retinoic acid decreases expression ISO RGD:736099 6480464 Tretinoin results in decreased expression of ANXA2 mRNA, Tretinoin results in decreased expression of ANXA2 protein CTD PMID:12165291 more ... all-trans-retinoic acid multiple interactions ISO RGD:731825 6480464 [bisphenol F co-treated with Tretinoin] results in decreased expression of ANXA2 mRNA CTD PMID:30951980 all-trans-retinoic acid multiple interactions ISO RGD:736099 6480464 Tretinoin affects the localization of and results in decreased expression of ANXA2 protein CTD PMID:12165291 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of ANXA2 mRNA CTD PMID:16483693 amphetamine increases expression EXP 6480464 Amphetamine results in increased expression of ANXA2 mRNA CTD PMID:30779732 aniline increases expression ISO RGD:731825 6480464 aniline results in increased expression of ANXA2 mRNA CTD PMID:22016648 arsane affects expression ISO RGD:736099 6480464 Arsenic affects the expression of ANXA2 mRNA CTD PMID:18414638 arsenic atom affects expression ISO RGD:736099 6480464 Arsenic affects the expression of ANXA2 mRNA CTD PMID:18414638 arsenous acid multiple interactions ISO RGD:736099 6480464 Arsenic Trioxide affects the localization of and results in decreased expression of ANXA2 protein, Arsenic Trioxide results in decreased expression of and results in increased degradation of ANXA2 mRNA CTD PMID:12165291 arsenous acid decreases response to substance ISO RGD:736099 6480464 ANXA2 protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 arsenous acid decreases expression ISO RGD:736099 6480464 Arsenic Trioxide results in decreased expression of ANXA2 mRNA, Arsenic Trioxide results in decreased expression of ANXA2 protein CTD PMID:19642359 more ... arsenous acid increases expression ISO RGD:736099 6480464 Arsenic Trioxide results in increased expression of ANXA2 mRNA CTD PMID:17547211 asbestos affects expression ISO RGD:736099 6480464 Asbestos affects the expression of ANXA2 mRNA CTD PMID:20682992 belinostat increases expression ISO RGD:736099 6480464 belinostat results in increased expression of ANXA2 mRNA CTD PMID:26272509 belinostat multiple interactions ISO RGD:736099 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANXA2 mRNA CTD PMID:27188386 benzo[a]pyrene increases expression ISO RGD:731825 6480464 Benzo(a)pyrene results in increased expression of ANXA2 mRNA CTD PMID:22228805 benzo[a]pyrene decreases expression ISO RGD:731825 6480464 Benzo(a)pyrene results in decreased expression of ANXA2 mRNA CTD PMID:19770486 , PMID:25908611 benzo[e]pyrene increases methylation ISO RGD:736099 6480464 benzo(e)pyrene results in increased methylation of ANXA2 intron CTD PMID:30157460 bis(2-ethylhexyl) phthalate increases expression ISO RGD:736099 6480464 Diethylhexyl Phthalate results in increased expression of ANXA2 mRNA CTD PMID:31163220 bisphenol A increases expression ISO RGD:736099 6480464 bisphenol A results in increased expression of ANXA2 mRNA CTD PMID:15223131 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of ANXA2 mRNA CTD PMID:30816183 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of ANXA2 mRNA, bisphenol A results in increased expression of ANXA2 protein CTD PMID:22649256 , PMID:25181051 bisphenol A increases expression ISO RGD:731825 6480464 bisphenol A results in increased expression of ANXA2 mRNA CTD PMID:26063408 , PMID:30951980 bisphenol A decreases expression ISO RGD:736099 6480464 bisphenol A results in decreased expression of ANXA2 mRNA CTD PMID:25047013 , PMID:29275510 bisphenol F multiple interactions ISO RGD:731825 6480464 [bisphenol F co-treated with Tretinoin] results in decreased expression of ANXA2 mRNA CTD PMID:30951980 bisphenol F increases expression ISO RGD:731825 6480464 bisphenol F results in increased expression of ANXA2 mRNA CTD PMID:30951980 bleomycin A2 decreases expression EXP 6480464 Bleomycin results in decreased expression of ANXA2 protein CTD PMID:25933445 bucladesine multiple interactions ISO RGD:736099 6480464 [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of ANXA2 mRNA CTD PMID:20823114 cadmium atom increases expression ISO RGD:736099 6480464 Cadmium results in increased expression of ANXA2 mRNA CTD PMID:17547211 , PMID:24376830 cadmium dichloride increases expression ISO RGD:736099 6480464 Cadmium Chloride results in increased expression of ANXA2 mRNA CTD PMID:17547211 cadmium dichloride affects expression EXP 6480464 Cadmium Chloride affects the expression of ANXA2 mRNA CTD PMID:22110744 calcitriol increases expression ISO RGD:736099 6480464 Calcitriol results in increased expression of ANXA2 mRNA CTD PMID:21592394 calcitriol multiple interactions ISO RGD:736099 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of ANXA2 mRNA CTD PMID:21592394 carbon nanotube affects expression ISO RGD:731825 6480464 Nanotubes, Carbon affects the expression of ANXA2 protein CTD PMID:21135415 carbon nanotube decreases secretion ISO RGD:731825 6480464 Nanotubes, Carbon results in decreased secretion of ANXA2 protein CTD PMID:25598225 carbon nanotube increases expression ISO RGD:731825 6480464 Nanotubes, Carbon results in increased expression of ANXA2 mRNA CTD PMID:25554681 carbon nanotube decreases expression ISO RGD:731825 6480464 Nanotubes, Carbon analog results in decreased expression of ANXA2 mRNA CTD PMID:25620056 carbonyl sulfide increases expression EXP 6480464 carbonyl sulfide results in increased expression of ANXA2 mRNA CTD PMID:19395590 chloroform increases expression EXP 6480464 Chloroform results in increased expression of ANXA2 mRNA CTD PMID:21813463 chloropicrin increases expression ISO RGD:736099 6480464 chloropicrin results in increased expression of ANXA2 mRNA CTD PMID:26352163 cholesterol multiple interactions ISO RGD:731825 6480464 [Cholesterol co-treated with 1, 2-dioleoyloxy-3-(trimethylammonium)propane] results in increased expression of ANXA2 mRNA CTD PMID:22129739 choline multiple interactions ISO RGD:731825 6480464 [Dietary Fats co-treated with Choline deficiency] results in increased expression of ANXA2 mRNA more ... CTD PMID:20938992 , PMID:29246445 chromium atom increases expression ISO RGD:736099 6480464 Chromium results in increased expression of ANXA2 mRNA CTD PMID:17547211 ciprofibrate increases expression ISO RGD:731825 6480464 ciprofibrate results in increased expression of ANXA2 mRNA CTD PMID:12771043 cisplatin decreases expression ISO RGD:731825 6480464 Cisplatin results in decreased expression of ANXA2 protein CTD PMID:29733421 clofibrate increases expression ISO RGD:731825 6480464 Clofibrate results in increased expression of ANXA2 mRNA CTD PMID:17585979 clofibric acid affects expression EXP 6480464 Clofibric Acid affects the expression of ANXA2 mRNA CTD PMID:17602206 cobalt dichloride increases expression EXP 6480464 cobaltous chloride results in increased expression of ANXA2 mRNA, cobaltous chloride results in increased expression of ANXA2 protein CTD PMID:24386269 copper atom decreases expression EXP 6480464 Copper results in decreased expression of ANXA2 mRNA CTD PMID:30556269 copper(0) decreases expression EXP 6480464 Copper results in decreased expression of ANXA2 mRNA CTD PMID:30556269 copper(II) sulfate increases expression ISO RGD:736099 6480464 Copper Sulfate results in increased expression of ANXA2 mRNA CTD PMID:19549813 coumestrol multiple interactions ISO RGD:736099 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ANXA2 mRNA CTD PMID:19167446 CU-O LINKAGE decreases phosphorylation ISO RGD:736099 6480464 cupric oxide results in decreased phosphorylation of ANXA2 protein CTD PMID:25470785 cyclosporin A decreases expression ISO RGD:736099 6480464 Cyclosporine results in decreased expression of ANXA2 mRNA CTD PMID:22147139 cytarabine decreases expression ISO RGD:736099 6480464 Cytarabine results in decreased expression of ANXA2 mRNA CTD PMID:21198554 cytarabine increases expression ISO RGD:736099 6480464 Cytarabine results in increased expression of ANXA2 mRNA CTD PMID:12165291 daunorubicin decreases expression ISO RGD:736099 6480464 Daunorubicin results in decreased expression of ANXA2 mRNA, Daunorubicin results in decreased expression of ANXA2 protein CTD PMID:21223737 diarsenic trioxide multiple interactions ISO RGD:736099 6480464 Arsenic Trioxide affects the localization of and results in decreased expression of ANXA2 protein, Arsenic Trioxide results in decreased expression of and results in increased degradation of ANXA2 mRNA CTD PMID:12165291 diarsenic trioxide decreases response to substance ISO RGD:736099 6480464 ANXA2 protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 diarsenic trioxide decreases expression ISO RGD:736099 6480464 Arsenic Trioxide results in decreased expression of ANXA2 mRNA, Arsenic Trioxide results in decreased expression of ANXA2 protein CTD PMID:19642359 more ... diarsenic trioxide increases expression ISO RGD:736099 6480464 Arsenic Trioxide results in increased expression of ANXA2 mRNA CTD PMID:17547211 dichlorine multiple interactions EXP 6480464 [Ozone co-treated with Chlorine] results in decreased expression of ANXA2 mRNA CTD PMID:18636392 dichlorine increases expression EXP 6480464 Chlorine results in increased expression of ANXA2 mRNA CTD PMID:18636392 dichlorvos increases expression EXP 6480464 Dichlorvos results in increased expression of ANXA2 mRNA CTD PMID:21813463 dicrotophos decreases expression ISO RGD:736099 6480464 dicrotophos results in decreased expression of ANXA2 mRNA CTD PMID:28302478 dihydroartemisinin affects binding ISO RGD:736099 6480464 dihydroartemisinin analog binds to ANXA2 protein CTD PMID:26340163 dioxygen affects expression ISO RGD:731825 6480464 Oxygen deficiency affects the expression of ANXA2 mRNA CTD PMID:17193925 diuron decreases expression EXP 6480464 Diuron results in decreased expression of ANXA2 mRNA CTD PMID:21551480 dorsomorphin multiple interactions ISO RGD:736099 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin increases expression ISO RGD:731825 6480464 Doxorubicin results in increased expression of ANXA2 mRNA CTD PMID:22016648 doxorubicin increases expression ISO RGD:736099 6480464 Doxorubicin results in increased expression of ANXA2 mRNA CTD PMID:29803840 Enterolactone multiple interactions ISO RGD:736099 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ANXA2 mRNA CTD PMID:19167446 entinostat increases expression ISO RGD:736099 6480464 entinostat results in increased expression of ANXA2 mRNA CTD PMID:26272509 , PMID:27188386 entinostat multiple interactions ISO RGD:736099 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANXA2 mRNA CTD PMID:27188386 enzyme inhibitor multiple interactions ISO RGD:736099 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of ANXA2 protein CTD PMID:23301498 fenamidone increases expression ISO RGD:731825 6480464 fenamidone results in increased expression of ANXA2 mRNA CTD PMID:27029645 folic acid multiple interactions ISO RGD:731825 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ANXA2 mRNA CTD PMID:20938992 fumonisin B1 increases expression ISO RGD:731825 6480464 fumonisin B1 results in increased expression of ANXA2 mRNA CTD PMID:16221962 furan increases expression EXP 6480464 furan results in increased expression of ANXA2 mRNA CTD PMID:15120968 more ... genistein decreases expression EXP 6480464 Genistein results in decreased expression of ANXA2 protein CTD PMID:22649256 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of ANXA2 mRNA CTD PMID:22061828 glyphosate increases expression ISO RGD:731825 6480464 glyphosate results in increased expression of ANXA2 protein CTD PMID:20045496 griseofulvin increases expression ISO RGD:731825 6480464 Griseofulvin results in increased expression of ANXA2 mRNA CTD PMID:12735108 hexadecanoic acid multiple interactions ISO RGD:736099 6480464 [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] results in increased expression of ANXA2 mRNA, [Palmitic Acid co-treated with Oleic Acid] affects the expression of ANXA2 mRNA CTD PMID:30547786 hyaluronic acid multiple interactions EXP 6480464 Hyaluronic Acid analog inhibits the reaction [Hydrogen Peroxide results in decreased expression of ANXA2 protein] CTD PMID:23178681 hydralazine multiple interactions ISO RGD:736099 6480464 [Hydralazine co-treated with Valproic Acid] results in increased expression of ANXA2 mRNA CTD PMID:17183730 hydrogen peroxide decreases expression EXP 6480464 Hydrogen Peroxide results in decreased expression of ANXA2 protein CTD PMID:23178681 hydrogen peroxide multiple interactions EXP 6480464 Hyaluronic Acid analog inhibits the reaction [Hydrogen Peroxide results in decreased expression of ANXA2 protein] CTD PMID:23178681 ibuprofen affects expression ISO RGD:736099 6480464 Ibuprofen affects the expression of ANXA2 protein CTD PMID:18351690 ICI D1694 increases expression ISO RGD:736099 6480464 raltitrexed results in increased expression of ANXA2 mRNA CTD PMID:15152939 ICI D1694 multiple interactions ISO RGD:736099 6480464 TYMS protein inhibits the reaction [raltitrexed results in increased expression of ANXA2 mRNA] CTD PMID:15152939 irinotecan increases expression ISO RGD:736099 6480464 Irinotecan results in increased expression of ANXA2 mRNA CTD PMID:15152939 iron atom increases expression ISO RGD:736099 6480464 Iron deficiency results in increased expression of ANXA2 mRNA CTD PMID:20368581 iron(0) increases expression ISO RGD:736099 6480464 Iron deficiency results in increased expression of ANXA2 mRNA CTD PMID:20368581 iron(III) nitrilotriacetate increases expression EXP 6480464 ferric nitrilotriacetate results in increased expression of ANXA2 mRNA CTD PMID:10854235 isobutanol multiple interactions ISO RGD:736099 6480464 [[Gasoline co-treated with isobutyl alcohol] results in increased chemical synthesis of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of ANXA2 mRNA CTD PMID:29432896 isoflavones multiple interactions EXP 6480464 [9 more ... CTD PMID:22248470 L-methionine multiple interactions ISO RGD:731825 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ANXA2 mRNA CTD PMID:20938992 lead(0) decreases expression ISO RGD:736099 6480464 Lead results in decreased expression of ANXA2 mRNA CTD PMID:19921347 lead(0) affects binding ISO RGD:736099 6480464 ANXA2 protein binds to Lead CTD PMID:23896426 lead(2+) decreases expression ISO RGD:736099 6480464 Lead results in decreased expression of ANXA2 mRNA CTD PMID:19921347 lead(2+) affects binding ISO RGD:736099 6480464 ANXA2 protein binds to Lead CTD PMID:23896426 leflunomide decreases expression EXP 6480464 leflunomide results in decreased expression of ANXA2 mRNA CTD PMID:24136188 levofloxacin decreases expression EXP 6480464 Levofloxacin results in decreased expression of ANXA2 mRNA CTD PMID:24136188 lipopolysaccharide increases expression ISO RGD:731825 6480464 Lipopolysaccharides results in increased expression of ANXA2 mRNA CTD PMID:27339419 lithium atom decreases expression EXP 6480464 Lithium results in decreased expression of ANXA2 protein CTD PMID:18296634 lithium hydride decreases expression EXP 6480464 Lithium results in decreased expression of ANXA2 protein CTD PMID:18296634 lithocholic acid multiple interactions ISO RGD:731825 6480464 Pregnenolone Carbonitrile inhibits the reaction [Lithocholic Acid results in increased expression of ANXA2 mRNA] CTD PMID:20359477 lithocholic acid increases expression ISO RGD:731825 6480464 Lithocholic Acid results in increased expression of ANXA2 mRNA CTD PMID:20359477 mancozeb decreases expression ISO RGD:731825 6480464 mancozeb results in decreased expression of ANXA2 protein CTD PMID:21375462 medroxyprogesterone acetate multiple interactions ISO RGD:736099 6480464 [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of ANXA2 mRNA CTD PMID:20823114 mercury atom increases expression ISO RGD:736099 6480464 Mercury results in increased expression of ANXA2 mRNA CTD PMID:17547211 mercury dibromide increases expression ISO RGD:736099 6480464 mercuric bromide results in increased expression of ANXA2 mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO RGD:736099 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANXA2 mRNA CTD PMID:27188386 mercury(0) increases expression ISO RGD:736099 6480464 Mercury results in increased expression of ANXA2 mRNA CTD PMID:17547211 methapyrilene increases expression EXP 6480464 Methapyrilene results in increased expression of ANXA2 mRNA CTD PMID:15120968 , PMID:21813463 methapyrilene increases methylation ISO RGD:736099 6480464 Methapyrilene results in increased methylation of ANXA2 intron CTD PMID:30157460 methylmercury chloride increases expression ISO RGD:736099 6480464 methylmercuric chloride results in increased expression of ANXA2 mRNA CTD PMID:28001369 microcystin-LR increases expression ISO RGD:731825 6480464 cyanoginosin LR results in increased expression of ANXA2 mRNA CTD PMID:17654400 N-methyl-4-phenylpyridinium affects expression ISO RGD:736099 6480464 1-Methyl-4-phenylpyridinium affects the expression of ANXA2 mRNA CTD PMID:12710931 N-methyl-4-phenylpyridinium increases expression ISO RGD:731825 6480464 1-Methyl-4-phenylpyridinium results in increased expression of ANXA2 protein CTD PMID:26558463 N-methyl-4-phenylpyridinium increases expression ISO RGD:736099 6480464 1-Methyl-4-phenylpyridinium results in increased expression of ANXA2 protein CTD PMID:24675778 N-nitrosodiethylamine increases expression EXP 6480464 Diethylnitrosamine results in increased expression of ANXA2 mRNA CTD PMID:19638242 , PMID:21813463 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of ANXA2 mRNA CTD PMID:28943392 N-nitrosodiethylamine increases expression ISO RGD:731825 6480464 Diethylnitrosamine results in increased expression of ANXA2 mRNA CTD PMID:12771043 , PMID:24535843 N-nitrosodiethylamine multiple interactions ISO RGD:731825 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of ANXA2 mRNA CTD PMID:24535843 N-nitrosodimethylamine increases expression EXP 6480464 Dimethylnitrosamine results in increased expression of ANXA2 mRNA CTD PMID:14600272 , PMID:25380136 N-nitrosodimethylamine increases expression ISO RGD:736099 6480464 Dimethylnitrosamine results in increased expression of ANXA2 mRNA CTD PMID:17547211 nickel atom increases expression ISO RGD:736099 6480464 Nickel results in increased expression of ANXA2 mRNA CTD PMID:25583101 nickel dichloride affects expression EXP 6480464 nickel chloride affects the expression of ANXA2 mRNA CTD PMID:22110744 nickel dichloride increases expression ISO RGD:736099 6480464 nickel chloride results in increased expression of ANXA2 protein CTD PMID:11250053 nickel sulfate increases expression ISO RGD:736099 6480464 nickel sulfate results in increased expression of ANXA2 mRNA CTD PMID:16314067 ochratoxin A increases expression EXP 6480464 ochratoxin A results in increased expression of ANXA2 mRNA CTD PMID:12700408 , PMID:18417182 oleic acid multiple interactions ISO RGD:736099 6480464 [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] results in increased expression of ANXA2 mRNA, [Palmitic Acid co-treated with Oleic Acid] affects the expression of ANXA2 mRNA CTD PMID:30547786 ouabain affects expression ISO RGD:736099 6480464 Ouabain affects the expression of ANXA2 protein CTD PMID:17268060 oxaliplatin increases expression ISO RGD:736099 6480464 oxaliplatin results in increased expression of ANXA2 mRNA CTD PMID:15152939 ozone multiple interactions EXP 6480464 [Ozone co-treated with Chlorine] results in decreased expression of ANXA2 mRNA CTD PMID:18636392 p-chloromercuribenzoic acid increases expression ISO RGD:736099 6480464 p-Chloromercuribenzoic Acid results in increased expression of ANXA2 mRNA CTD PMID:26272509 p-chloromercuribenzoic acid multiple interactions ISO RGD:736099 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANXA2 mRNA CTD PMID:27188386 p-toluidine increases expression EXP 6480464 4-toluidine results in increased expression of ANXA2 mRNA CTD PMID:27638505 panobinostat increases expression ISO RGD:736099 6480464 panobinostat results in increased expression of ANXA2 mRNA CTD PMID:26272509 panobinostat multiple interactions ISO RGD:736099 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANXA2 mRNA CTD PMID:27188386 paracetamol increases expression ISO RGD:731825 6480464 Acetaminophen results in increased expression of ANXA2 mRNA CTD PMID:24126418 , PMID:29246445 paracetamol multiple interactions ISO RGD:731825 6480464 PANX1 gene mutant form inhibits the reaction [Acetaminophen results in increased expression of ANXA2 mRNA] CTD PMID:29246445 paraquat increases expression EXP 6480464 Paraquat results in increased expression of ANXA2 protein CTD PMID:24521700 phenobarbital multiple interactions ISO RGD:731825 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of ANXA2 mRNA, NR1I3 protein affects the reaction [Phenobarbital results in increased expression of ANXA2 mRNA] CTD PMID:19482888 , PMID:24535843 phenobarbital increases expression ISO RGD:731825 6480464 Phenobarbital results in increased expression of ANXA2 mRNA CTD PMID:19482888 phenobarbital increases methylation ISO RGD:731825 6480464 Phenobarbital results in increased methylation of ANXA2 promoter CTD PMID:19482888 phenobarbital affects methylation ISO RGD:731825 6480464 Phenobarbital affects the methylation of ANXA2 gene CTD PMID:19233941 phenylmercury acetate increases expression ISO RGD:736099 6480464 Phenylmercuric Acetate results in increased expression of ANXA2 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:736099 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANXA2 mRNA CTD PMID:27188386 phorbol 13-acetate 12-myristate increases expression ISO RGD:731825 6480464 Tetradecanoylphorbol Acetate results in increased expression of ANXA2 protein CTD PMID:20045496 pirinixic acid multiple interactions ISO RGD:731825 6480464 [pirinixic acid co-treated with PPARA] results in increased expression of ANXA2 mRNA more ... CTD PMID:16221962 more ... pirinixic acid increases expression ISO RGD:731825 6480464 pirinixic acid results in increased expression of ANXA2 mRNA CTD PMID:16221962 more ... poly(propylene imine) macromolecule increases expression ISO RGD:736099 6480464 poly(propyleneimine) analog results in increased expression of ANXA2 mRNA CTD PMID:16308212 potassium dichromate increases expression ISO RGD:736099 6480464 Potassium Dichromate results in increased expression of ANXA2 mRNA CTD PMID:17547211 pregnenolone 16alpha-carbonitrile multiple interactions ISO RGD:731825 6480464 Pregnenolone Carbonitrile inhibits the reaction [Lithocholic Acid results in increased expression of ANXA2 mRNA] CTD PMID:20359477 quercetin increases expression ISO RGD:736099 6480464 Quercetin results in increased expression of ANXA2 protein CTD PMID:15221776 quercetin decreases expression EXP 6480464 Quercetin results in decreased expression of ANXA2 protein CTD PMID:18095365 quinoline increases expression ISO RGD:736099 6480464 quinoline analog results in increased expression of ANXA2 protein CTD PMID:18645022 rac-lactic acid increases expression ISO RGD:736099 6480464 Lactic Acid results in increased expression of ANXA2 mRNA CTD PMID:30851411 resveratrol increases expression ISO RGD:736099 6480464 resveratrol results in increased expression of ANXA2 mRNA, resveratrol results in increased expression of ANXA2 protein CTD PMID:18089832 , PMID:23750556 rotenone increases expression ISO RGD:731825 6480464 Rotenone results in increased expression of ANXA2 mRNA CTD PMID:22016648 , PMID:23186747 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of ANXA2 mRNA CTD PMID:28374803 SB 431542 multiple interactions ISO RGD:736099 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silicon dioxide affects secretion ISO RGD:736099 6480464 Silicon Dioxide analog affects the secretion of ANXA2 protein CTD PMID:25895662 sodium arsenite affects expression ISO RGD:731825 6480464 sodium arsenite affects the expression of ANXA2 mRNA CTD PMID:16507464 sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of ANXA2 protein CTD PMID:29459688 sodium dichromate decreases expression ISO RGD:731825 6480464 sodium bichromate results in decreased expression of ANXA2 mRNA CTD PMID:22155349 sodium dichromate increases expression EXP 6480464 sodium bichromate results in increased expression of ANXA2 mRNA CTD PMID:25993096 sodium dichromate decreases expression ISO RGD:736099 6480464 sodium bichromate results in decreased expression of ANXA2 mRNA CTD PMID:17685462 sodium dichromate increases expression ISO RGD:731825 6480464 sodium bichromate results in increased expression of ANXA2 mRNA CTD PMID:22155349 sodium fluoride decreases expression ISO RGD:731825 6480464 Sodium Fluoride results in decreased expression of ANXA2 protein CTD PMID:28918527 sodium fluoride increases expression ISO RGD:731825 6480464 Sodium Fluoride results in increased expression of ANXA2 protein CTD PMID:27548804 Soman increases expression EXP 6480464 Soman results in increased expression of ANXA2 mRNA CTD PMID:19281266 sulfasalazine increases expression ISO RGD:731825 6480464 Sulfasalazine results in increased expression of ANXA2 mRNA CTD PMID:22016648 tamibarotene decreases expression ISO RGD:736099 6480464 tamibarotene results in decreased expression of ANXA2 mRNA CTD PMID:15498508 tamoxifen affects expression ISO RGD:731825 6480464 Tamoxifen affects the expression of ANXA2 mRNA CTD PMID:17555576 testosterone multiple interactions ISO RGD:736099 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of ANXA2 mRNA CTD PMID:21592394 testosterone increases expression ISO RGD:736099 6480464 Testosterone results in increased expression of ANXA2 mRNA CTD PMID:21592394 tetrachloromethane increases expression ISO RGD:731825 6480464 Carbon Tetrachloride results in increased expression of ANXA2 mRNA CTD PMID:27339419 , PMID:29987408 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of ANXA2 mRNA CTD PMID:31150632 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of ANXA2 mRNA] CTD PMID:31150632 thalidomide decreases expression ISO RGD:736099 6480464 Thalidomide results in decreased expression of ANXA2 mRNA, Thalidomide results in decreased expression of ANXA2 protein CTD PMID:19954599 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of ANXA2 mRNA CTD PMID:23411599 thioacetamide multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of ANXA2 mRNA CTD PMID:28943392 titanium dioxide decreases phosphorylation ISO RGD:736099 6480464 titanium dioxide results in decreased phosphorylation of ANXA2 protein CTD PMID:21439344 trichostatin A multiple interactions ISO RGD:736099 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:19294695 , PMID:27188386 trichostatin A increases expression ISO RGD:736099 6480464 trichostatin A results in increased expression of ANXA2 mRNA, trichostatin A results in increased expression of ANXA2 protein CTD PMID:19294695 more ... trimellitic anhydride increases expression ISO RGD:731825 6480464 trimellitic anhydride results in increased expression of ANXA2 mRNA CTD PMID:19042947 tris(2-butoxyethyl) phosphate affects expression ISO RGD:736099 6480464 tris(2-butoxyethyl) phosphate affects the expression of ANXA2 mRNA CTD PMID:29024780 tungsten decreases expression ISO RGD:731825 6480464 Tungsten results in decreased expression of ANXA2 mRNA CTD PMID:30912803 urethane decreases expression ISO RGD:736099 6480464 Urethane results in decreased expression of ANXA2 mRNA CTD PMID:28818685 valproic acid multiple interactions ISO RGD:736099 6480464 [Hydralazine co-treated with Valproic Acid] results in increased expression of ANXA2 mRNA more ... CTD PMID:17183730 , PMID:27188386 valproic acid decreases expression ISO RGD:731825 6480464 Valproic Acid results in decreased expression of ANXA2 mRNA CTD PMID:31445079 valproic acid increases expression ISO RGD:736099 6480464 Valproic Acid results in increased expression of ANXA2 mRNA CTD PMID:19101580 more ... valproic acid affects expression ISO RGD:736099 6480464 Valproic Acid affects the expression of ANXA2 mRNA CTD PMID:25979313 valproic acid affects expression ISO RGD:731825 6480464 Valproic Acid affects the expression of ANXA2 mRNA CTD PMID:17292431 vancomycin decreases expression ISO RGD:731825 6480464 Vancomycin results in decreased expression of ANXA2 mRNA CTD PMID:18930951 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of ANXA2 mRNA CTD PMID:19015723 vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of ANXA2 mRNA CTD PMID:23034163 vincristine increases expression ISO RGD:736099 6480464 Vincristine results in increased expression of ANXA2 mRNA CTD PMID:23649840 vitamin D affects expression ISO RGD:736099 6480464 Vitamin D affects the expression of ANXA2 mRNA CTD PMID:20368581 vorinostat multiple interactions ISO RGD:736099 6480464 [Decitabine co-treated with Vorinostat] affects the expression of ANXA2 mRNA more ... CTD PMID:17330099 , PMID:27188386 vorinostat increases expression ISO RGD:736099 6480464 vorinostat results in increased expression of ANXA2 mRNA CTD PMID:26272509 , PMID:27188386 zinc atom decreases expression EXP 6480464 Zinc results in decreased expression of ANXA2 mRNA CTD PMID:17074742 zinc sulfate decreases expression EXP 6480464 Zinc Sulfate results in decreased expression of ANXA2 mRNA CTD PMID:17074742 zinc sulfate affects expression ISO RGD:736099 6480464 Zinc Sulfate affects the expression of ANXA2 protein CTD PMID:25162517 zinc(0) decreases expression EXP 6480464 Zinc results in decreased expression of ANXA2 mRNA CTD PMID:17074742 zoledronic acid decreases expression ISO RGD:736099 6480464 zoledronic acid results in decreased expression of ANXA2 protein CTD PMID:28871336
Gene-Chemical Interaction Annotations
